Infectious Disease Diagnostic Market Production Technology, Cost Analysis, and Demand Forecast by Region and Application Through 2032

𝐀𝐜𝐜𝐨𝐫𝐝𝐢𝐧𝐠 𝐭𝐨 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐩𝐫𝐞𝐝𝐢𝐜𝐭𝐢𝐨𝐧𝐬, 𝐭𝐡𝐞 𝐢𝐧𝐟𝐞𝐜𝐭𝐢𝐨𝐮𝐬 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐔𝐒𝐃 𝟐𝟏.𝟔𝟕 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑. 𝐓𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐚𝐧𝐭𝐢𝐜𝐢𝐩𝐚𝐭𝐞𝐝 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐭𝐨 𝐔𝐒𝐃 𝟒𝟐.𝟑𝟗 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐, 𝐞𝐱𝐡𝐢𝐛𝐢𝐭𝐢𝐧𝐠 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟕.𝟖% 𝐝𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝.

The market growth is primarily fuelled by the growing existence of infectious diseases, progression in technology, and escalating consciousness about premature diagnosis and treatment. The growing existence of communicable diseases such as influenza, HIV, and hepatitis are prominent propellers of the market growth. Additionally, the surfacing of contemporary diseases and the menace of outbreaks has escalated the demand for speedy and precise diagnostic tests. Also, technological progressions in molecular diagnostics, such as PCR-dependent assays, next-generation sequencing, and point-of-care testing, have enhanced the preciseness and the momentum of diagnostic tests, rendering them more reachable and inexpensive.

𝐆𝐞𝐭 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/industry-analysis/infectious-disease-diagnostic-market/request-for-sample

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐨𝐧 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬

The market is a speedily advancing field with several critical players diligently engaged in advancing and commercializing contemporary diagnostic tests and technologies. Some of the current players in the infectious disease diagnostic market are:

Abbott
Becton Dickinson
bioMérieux
Bio-Rad Laboratories
Cepheid
Danaher
F. Hoffmann-La Roche Ltd
Hologic Inc.
Luminex Corporation
Qiagen Inc.
Thermo Fisher Scientific Inc.

𝐈𝐧𝐟𝐞𝐜𝐭𝐢𝐨𝐮𝐬 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬

In 2023, the reagents, kits, and consumables generated the highest revenue share within the product segment. This is mainly attributable to the growing incidence of infectious diseases, resulting in a corresponding increase in demand for diagnostic tests. As a result, sales of reagents, kits, and consumables have surged, driving up their revenue share in the market.
In 2023, the laboratory testing segment held the major share of the market, and this was due to the critical role played by laboratory testing in identifying and tracking various infectious diseases.
The market has been significantly influenced by the pandemic, with COVID-19 being the dominating segment in disease type. This is attributed to the massive scale of the pandemic and the critical requirement for precise and prompt diagnosis of the virus.
In 2023, the North American region take the lead position, thanks to the strong healthcare infrastructure and advanced medical facilities in countries like the United States and Canada. These factors played a significant role in contributing to the region's market share.

𝐎𝐫𝐝𝐞𝐫 𝐘𝐨𝐮𝐫 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 𝐍𝐨𝐰:
https://www.polarismarketresearch.com/buy/3174/2

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬

North America dominated the infectious disease diagnostic market. The region's growth is primarily fuelled by the existence of an entrenched healthcare framework and progressive medical potential in nations such as the U.S. and Canada, which bestowed notably towards the region's market share.
Owing to the elevated existence of infectious diseases in the region, especially in nations such as India, China, and Indonesia, and the growing cases of dengue fever, hepatitis, and malaria, the Asia Pacific region is projected to grow at a rapid pace.

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰

Infectious Disease Diagnostic, Product Outlook (Revenue - USD Billion, 2019 - 2032)

Reagents, Kits, and Consumables
Instruments
Software and Services

Infectious Disease Diagnostic, Type of Testing Outlook (Revenue - USD Billion, 2019 - 2032)

Laboratory Testing
PoC Testing

𝐀𝐜𝐜𝐞𝐬𝐬 𝐘𝐨𝐮𝐫 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐍𝐨𝐰:
https://www.polarismarketresearch.com/industry-analysis/infectious-disease-diagnostic-market

𝐅𝐀𝐐'𝐬

What is the expected industry size of infectious disease diagnostics market?

Who are the top market players in the market?

Which region contribute notably towards the global infectious disease diagnostics market?

What will be the expected CAGR of infectious disease diagnostics market during the forecast period (2024-2032)

What are the key segments in the infectious disease diagnostics market?

𝐀𝐜𝐜𝐞𝐬𝐬 𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐏𝐌𝐑 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:

https://www.polarismarketresearch.com/industry-analysis/biotechnology-market

https://www.polarismarketresearch.com/industry-analysis/e-pharma-market

https://www.polarismarketresearch.com/industry-analysis/cell-culture-market

https://www.polarismarketresearch.com/industry-analysis/virus-filtration-market

https://www.polarismarketresearch.com/industry-analysis/viscosupplement-market

Contact Us:
Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

About Us:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.